In a report released today, Florent Cespedes from Bernstein maintained a Buy rating on Novartis AG (NOVN – Research Report), with a price ...
Novartis (NVS) “announced the FDA has granted accelerated approval for Vanrafia, or atrasentan, a potent and selective endothelin A receptor ...
Basel, March 20, 2025 - Novartis today announced that oral Fabhalta ® (iptacopan) has received U.S. Food and Drug Administration (FDA) approval for the treatment of adults with C3 glomerulopathy (C3G) ...
All dollar values are in U.S. dollars unless stated otherwise. Eupraxia Pharmaceuticals logo (CNW Group/Eupraxia Pharmaceuticals Inc.) On October 2, 2024, the Company announced the appointment of ...
Glenmark Pharmaceuticals Ltd. (BSE ... Inc., distributor of Pataday® Once Daily Relief, and/or Novartis AG, owner of the registered trademark Pataday®, respectively. [Neither Alcon nor Novartis ...
Novartis has announced positive results from a late-stage programme of its experimental gene replacement therapy in patients with the rare neuromuscular disease spinal muscular atrophy (SMA). The ...
ZURICH, March 19 (Reuters) - Swiss drugmaker Novartis (NOVN.S), opens new tab ... is a Britain-based reporter covering the European pharmaceuticals industry with a global perspective.
Large mergers and acquisitions in the Indian pharmaceutical market are unlikely soon due to various uncertainties, says GV Prasad of Dr Reddy's Laboratories. The company is focusing on diversifying ...
Trump critiqued Ireland's economic relationship with the US. Trump said that Ireland has taken advantage of US, accusing it of having the US pharmaceutical industry in its grip. This comes weeks after ...
BOSTON, March 13, 2025 (GLOBE NEWSWIRE) -- Today, Folia Health and Novartis Pharmaceuticals, Inc. proudly announce their collaboration on an innovative, at-home observational real-world evidence ...
The long-term, exclusive pharmaceutical category agreement is designed to turn fans' passion for the game into a commitment to better health Novartis sports partnership covers the NFL's marquee health ...
We can do better. Together with Susan G. Komen, Novartis is proud to announce the creation and launch of the Alliance for Breast Cancer Policy. The coalition comprises more than 20 partner ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results